美国触发的按需NO释放生物模拟纳米粒子将重塑内皮微环境,以增强动脉样硬化特异性气体治疗
Lingling Xu1, Daifang Zhang2,3, Li Song4
1Department of Ultrasound Medicine, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, 430022, China.
Materials today. Bio
|September 10, 2025
概括
仿生纳米粒子在需要时提供氧化 (NO),用于治疗动脉样硬化 (AS). 这种向的纳米疗法增强了内皮修复,并减少了炎症,用于精确治疗AS.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术 纳米技术
- 心血管研究研究心血管研究
背景情况:
- 动脉样硬化 (AS) 是一种慢性炎症性血管疾病,其特征是内皮功能障碍和光滑肌肉细胞增殖.
- 氧化 (NO) 对于血管平衡至关重要,但其治疗用途因不稳定性和缺乏向而受到限制.
- 目前的NO输送方法缺乏精确的控制和向动脉样硬化病变.
研究的目的:
- 开发一种仿生纳米粒子系统,以有针对性和可控地将氧化 (NO) 输送到动脉样硬化斑块.
- 为了利用超声波 (US) 响应,在需要时在疾病部位释放NO.
- 在AS的临床前模型中评估这种NO纳米疗法的治疗疗效.
主要方法:
- 制造聚乳-同-甘油酸 (PLGA) 纳米圈,封装一个超声响应的NO捐赠体 (BNN6).
- 用巨菌衍生膜涂层纳米球,以创建生物模拟纳米粒子 (B-NPs@MM) 用于主动准.
- 在实验室和体内对NO释放的评估,向效率,内皮修复,抗炎作用,并在局部暴露后抑制neointimal增生.
主要成果:
- 开发的B-NPs@MM有效地向炎症性动脉样硬化斑块,并逃避免疫清除.
- 局部超声波暴露触发了精确的,按需的NO从纳米颗粒中释放.
- 观察到内皮修复,减少炎症和抑制体内新极度增生症的显著改善.
结论:
- 仿生纳米粒子为AS治疗中NO纳米疗法提供了一个智能,远程控制的平台.
- 这种以人造免疫细胞为灵感的设计能够在病变部位提供精确的输送和治疗效果.
- 开发的NO纳米疗法为动脉样硬化的有针对性的管理提供了一个有希望的策略.
相关概念视频
01:28Nitric Oxide Signaling Pathway
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...